ADPTAdaptive Biotechnologies

Median target
$25
calls from the last 12 months
Implied return
-12.4%
median target vs. price
Coverage
8 analysts · 12 calls
updated in the last 12 months
Consensus
6/2/0+6 net
Buy / Hold / Sell

Which analysts are behind ADPT's consensus?

See every current rating, price target and the analysts' track records for Adaptive Biotechnologies — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 8 analysts with calls on ADPT updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

ADPT elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-09-16InsidersLo FrancisChief People OfficerInsider sale107.5K sh @ $28.02 · planned trade$3.0M
2026-09-16InsidersLo FrancisChief People OfficerInsider sale7.9K sh @ $28.57 · planned trade$225K
2026-09-15InsidersBobulsky SusanChief Commercial OfficerInsider sale1.2K sh @ $27.00 · planned trade$32K
2026-08-26InsidersOwen Katey EinterzDirectorInsider sale9.6K sh @ $26.00$250K
2026-08-18InsidersRobins Chad MCEO and ChairmanInsider sale278.5K sh @ $24.48$6.8M
2026-08-18InsidersHershberg RobertDirectorInsider sale15.7K sh @ $24.41$382K
2026-08-18InsidersHershberg RobertDirectorInsider sale15.0K sh @ $24.39$366K
2026-08-18InsidersRobins Chad MCEO and ChairmanInsider sale204 sh @ $25.14$5K
2026-08-17InsidersRobins Chad MCEO and ChairmanInsider sale318.8K sh @ $25.08$8.0M
2026-08-17InsidersNeupert Peter MDirectorInsider sale69.7K sh @ $25.16$1.8M

More: insider activity · executive branch · trending